PepGen promotes Michelle Mellion to CMO, Hayley Parker to SVP Global Regulatory Affairs

PepGen Inc.

Michelle Mellion, M.D., promoted to Chief Medical Officer effective immediately.
Hayley Parker, Ph.D., promoted to Senior Vice President, Global Regulatory Affairs effective immediately.
Mellion joined PepGen as SVP Head of Clinical Development; previously held roles at Fulcrum Therapeutics.
Parker joined PepGen as VP Regulatory Affairs; previously led regulatory strategy at Scholar Rock.
CEO McArthur cites their leadership in driving clinical and regulatory strategies for rare muscle disorders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.